GENE ONLINE|News &
Opinion
Blog

2021-04-19| SpecialTechnology

Towards Exosome-Based Theranostics for Alzheimer’s Disease

by GeneOnline
Share To
With high biocompatibility combined with the ability to pass through BBB and carry drug payloads, exosomes have huge potential in treating AD.

Exosomes by themselves or as vehicles for drug delivery offer a Trojan horse strategy that could be exploited for treatments. In summary, the utilization of exosomes as novel theranostics offers hope in treating a devastating disease like AD.

GO Prime with only $1.49 now

LATEST
Major U.S. Organization BIO Severs Ties With Member WuXi AppTec Amid U.S. Government’s Security Concerns
2024-03-15
Mayo Clinic Researchers Invent Hypothesis-Driven AI for Cancer Research Breakthroughs
2024-03-14
Chinese Biotechs Seeks IPO Growth on US Shores
2024-03-13
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
German Study Links PFAS Exposure to Adverse Lipid Profiles and Cardiovascular Risk
2024-03-13
Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evolving Market Dynamics
2024-03-12
Taiwanese Hospitals Make Strong Showing in “World’s Best Hospitals” Ranking
2024-03-12
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top